Optibrium and Integrated Chemistry Design Collaborat?e to Introduce Creative Compound Design on iPad

Optibrium and Integrated Chemistry Design, providers of software solutions and services for drug discovery, have announed the release of Asteris, a new iPad app that combines highly intuitive chemistry drawing tools with the most visually informative predictive modelling. Asteris enables creative researchers to rapidly evaluate new compound ideas when and where they want, no longer limited to sitting in an office or in front of a computer.
Asteris uses Chirys Draw’s patent pending chemical drawing tools, optimised specifically for the touch environment, allowing users to explore a much wider range of chemistry designs. Instant feedback from StarDrop’s predictive models, guided by the unique Glowing Molecule visualisation, dramatically reduces the time required to identify high quality compound designs. With Asteris users can calculate a range of “core properties”, such as logP, molecular weight, polar surface area, and hydrogen bond donors, and predict over ten ADME properties, including solubility, hERG inhibition, and CNS penetration.
Dr Matthew Segall, Optibrium’s CEO, commented: “We are very pleased to be working with Integrated Chemistry Design. The combination of our unique technologies in Asteris provides an innovative ideas space, giving users the flexibility to explore new compound designs, beyond the constraints of traditional computational tools. This collaboration furthers our on-going strategy to work with other leading developers of innovative solutions for drug discovery.”
Dr M. Catherine Johnson, President and CEO of Integrated Chemistry Design added: “We are excited that Asteris provides medicinal chemists with powerful tools for evaluating prospective drug ideas, and they can use Asteris anywhere, in meetings or on travel as well as in their offices. Using Asteris, drug designers will be able to assess ideas more quickly to converge on the most promising candidates for further study.”
Asteris will be launched at the American Chemical Society Spring 2014 National Meeting & Expo in Dallas, Texas from 16–20 March (visit Optibrium, booth #1516) and Integrated Chemistry Design (booth #400) to see Asteris in action. From 16 March, Asteris can be downloaded from the App Store.
Related News
-
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute. -
News 3 ways ChatGPT will impact pharma marketing teams
What does the rise of AI-powered chatbots such as ChatGPT and GPT-4 mean for pharma marketeers? -
News Eli Lilly, Novo Nordisk, and Sanofi cut insulin prices by up to 78%
Insulin prices have dropped in a stark play by the three biggest makers of the product, after calls from the top of the US government. -
News Open letter challenges EU Commission on medicine supply chain
In an open letter to the European Commission, Medicines for Europe calls for a new medicine security contract with their goal to improve access to medicine and ensure a secure supply chain to Europe.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance